In-vitro interaction of azithromycin and fluoroquinolones against gram-positive and gram-negative bacteria  Matthew W. Ruble, Deborah H. Gilbert, Stephen.

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents
Approach to diagnosis of infective endocarditis
Time-trends for Gram-negative and multidrug-resistant Gram-positive bacteria associated with nosocomial infections in German intensive care units between.
Correlation between the activity of different fluoroquinolones and the presence of mechanisms of quinolone resistance in epidemiologically related and.
Control of multidrug-resistant Gram-negative bacteria in low- and middle-income countries—high impact interventions without much resources  N. Singh,
The efficacy and safety of daptomycin: first in a new class of antibiotics for Gram- positive bacteria  M.J. Rybak  Clinical Microbiology and Infection 
Herpes zoster in non-hospitalized children
In vitro activity of several antimicrobial peptides against colistin-susceptible and colistin- resistant Acinetobacter baumannii  X. Vila-Farres, C. Garcia.
Antimicrobial Activity of SCH 27899, Oligosaccharide Member of the Everninomycin Class with a Wide Gram-Positive Spectrum  Ronald N. Jones, M.D., Mary.
Atypical respiratory pathogens
In vitro activity of cefpirome and vancomycin in combination against gentamicin- susceptible and gentamicin-resistant Staphylococcus aureus  A. Carricajo,
Use of antimicrobials and resistance in bacteria isolated from blood cultures in a Danish county from 1992 to 1995  Thomas Lund S⊘rensen, Niels Frimodt-M⊘ller,
Clinical impact of antibiotic-resistant Gram-positive pathogens
Controversies in guidelines for the control of multidrug-resistant Gram-negative bacteria in EU countries  J.A. Otter, N.T. Mutters, E. Tacconelli, A.
Hydatid disease Clinical Microbiology and Infection
Link between intracellular pathogens and cardiovascular diseases
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
W. Witte, B. Pasemann, C. Cuny  Clinical Microbiology and Infection 
In vitro activity, postantibiotic effect and human monocyte activity of grepafloxacin against Legionella species  Jacques Dubois, Claude St-Pierre  Clinical.
Odile Launay, Jean-Claude Nguyen Van, Annie Buu-Hoï, J.F. Acar 
Structure of grepafloxacin relative to activity and safety profile
Vector control: a cornerstone in the malaria elimination campaign
Evaluation of antibacterial activity of cefodizime, ceftriaxone and cefonicid in Klebsiella pneumoniae-infected guinea pigs  Lorenzo Drago, Barbara Mombelli,
Inga Odenholt, Elisabeth Löwdin, Otto Cars 
Spa typing directly from a mecA, spa and pvl multiplex PCR assay—a cost-effective improvement for methicillin-resistant Staphylococcus aureus surveillance 
C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins
Sofie Arens, Jan Verhaegen, Ludo Verbist 
Multicenter study of the in vitro activity of cefepime in comparison with five other broad- spectrum antibiotics against clinical isolates of Gram-positive.
Training for the infectious diseases speciality in Norway
The antibacterial effects of ciprofloxacin and trovafloxacin against Streptococcus pneumoniae in an in vitro dynamic model  Matthew O'Brien, Thuy Quach,
Pharmacodynamic properties of HMR 3004, a novel ketolide, on respiratory pathogens, enterococci and Bacteroides fragilis demonstrated by studies of time.
Cephalosporins: a pharmacological update
Low prevalence of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in Belgian hospitals  C. Nonhoff, O. Denis,
Epidemiology of opportunistic infections in AIDS patients
D. Esel, B. Sümerkan, S. Kocagöz  Clinical Microbiology and Infection 
Laboratory diagnosis and biosafety issues of biological warfare agents
Comparative in vitro pharmacodynamics of BO-2727, meropenem and imipenem against Gram-positive and Gram-negative bacteria  Inga Odenholt, Elisabeth Löwdin,
Sepsis and neutropenia induced by clozapine
Uncommon opportunistic fungi: new nosocomial threats
André Bryskier  Clinical Microbiology and Infection 
In vitro selection of antibiotic resistance in Pseudomonas aeruginosa
R. Bitterman, M. Paul, D. Polak, Y. Geffen 
L. Arreaza, J.A. Vázquez  Clinical Microbiology and Infection 
Erythromycin susceptibility of viridans streptococci from the normal throat flora of patients treated with azithromycin or clarithromycin  King A. , Bathgate.
Laboratory diagnosis of Clostridium difficile disease
Interactions between cytomegalovirus and the p53 tumor suppressor gene in atherosclerotic vascular disease  Inge O. Baas, G. Johan A. Offerhaus, Ralph.
Pathogenesis of catheter-related infections: lessons for new designs
J. Garau  Clinical Microbiology and Infection 
Community-acquired pneumonia: epidemiologic and clinical consideration
Comparative antimicrobial spectrum and activity of the desfluoroquinolone BMS (T-3811) tested against non-fermentative Gram-negative bacilli  W.
P.M. Hawkey  Clinical Microbiology and Infection 
Real-time PCR assays compared to culture-based approaches for identification of aerobic bacteria in chronic wounds  J.H. Melendez, Y.M. Frankel, A.T.
C. Gagliotti, L. Nobilio, M.L. Moro 
Correlation between time to positivity of blood cultures with clinical presentation and outcomes in patients with Klebsiella pneumoniae bacteraemia: prospective.
Clinical Microbiology and Infection
Clinical Microbiology and Infection
Overview of cefixime use in community-acquired infections
The in vitro activity of moxifloxacin against Haemophilus influenzae and Moraxella catarrhalis explored using a pharmacodynamic model  Alasdair P. MacGowan,
Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe  Robert D. Fox  Clinical Microbiology.
Abstracts Clinical Microbiology and Infection
New oral cephalosporins in pediatric community-acquired infections
J. Wilson, S. Elgohari, D. M. Livermore, B. Cookson, A. Johnson, T
In vitro activity of evernimicin and selected antibiotics against methicillin-resistant staphylococci: a 24-country study  R. Goering, C.-E. Nord, R.
Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group†   H. Goossens  Clinical.
J.L. Balcázar  Clinical Microbiology and Infection 
The DUEL study: a multi-center in vitro evaluation of linezolid compared with other antibiotics in the Netherlands  J.W. Mouton, A.R. Jansz  Clinical.
Typing of Clostridium difficile
New patterns of HIV-1 resistance during HAART
The future of diagnostic bacteriology
Presentation transcript:

In-vitro interaction of azithromycin and fluoroquinolones against gram-positive and gram-negative bacteria  Matthew W. Ruble, Deborah H. Gilbert, Stephen H. Zinner  Clinical Microbiology and Infection  Volume 1, Issue 3, Pages 183-189 (March 1996) DOI: 10.1111/j.1469-0691.1996.tb00551.x Copyright © 1996 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 1 Sample kill-curve patterns found with: (A) MRSA strains susceptible to lomefloxacin, but resistant to azithromycin, with FIC and FBC indices of 2 to 3 (strains J, 1707, 499 and 641), and Klebsiella pneumoniae 241; (B) MRSA strain 8495, resistant to lomefloxacin and azithromycin (FIC and FBC indices = 2 and 1.25); and (C) MSSA strains ATCC 25923, ATCC 29213, 401B, 1351B, 3221, 44B, 47B and MRSA 1281. Clinical Microbiology and Infection 1996 1, 183-189DOI: (10.1111/j.1469-0691.1996.tb00551.x) Copyright © 1996 European Society of Clinical Infectious Diseases Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.